Streams straight from the publisher. podnod never proxies or re-hosts episode audio.
In this episode of Denatured, you’ll hear from Lance Alstodt, chairman and CEO at Biorestorative Therapies, and Paul Mieyal, chief business officer at South Rampart Pharma. We explore why pain has remained such a difficult therapeutic area to tackle and one of the biggest unmet needs today, and how non-opioid mechanisms to regenerative therapies could reshape the future of treatment.
Host
Jennifer C. Smith-Parker, Director of Insights, BioSpace
Guests
Lance Alstodt, Chairman & CEO, BioRestorative Therapies
Paul Mieyal, Chief Business Officer, South Rampart Pharma
Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.
Jennifer C. Smith-Parker
linkedin.comLance Alstodt
linkedin.comPaul Mieyal,
linkedin.com